Is allergy immunotherapy-induced anaphylaxis still a real problem?

Purpose of review The current review describes the incidence and risk for anaphylaxis due to allergy injections. Recent findings The incidence of fatal anaphylaxis occurs with approximately one in 7.2 million injection visits. Severe anaphylaxis may occur once in every 160 000 visits. The major risk for fatal anaphylaxis is severe and uncontrolled asthma. Summary Understanding risk factors for anaphylaxis to allergy injections has led to clinic protocols aimed at preventing such events. The efficacy of these preventive measures remains to be determined in future studies.
Source: Current Opinion in Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: IMMUNOTHERAPY AND NEW TREATMENTS: Edited by Giovanni Passalacqua and Robert Bush Source Type: research